At a glance
ClinicalIndex Comparison RecordN/ACompleted· 744 enrolled
Drug / intervention
Micra Pacemaker Implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Micra Transcatheter Pacing Study
In Brief
A clinical study evaluating Micra Pacemaker Implant for Class I or II Indication for Implantation of a Single Chamber Ventricular Pacemaker According to ACC/AHA/HRS 2001 Guidelines and Any National Guidelines. Completed, enrolled 744 participants across 56 sites in 19 countries.
Detailed Summary
The purpose of this clinical study is to evaluate the safety and efficacy of the Micra Transcatheter Pacing System and to assess long term performance.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustralia, Austria, Canada, China, Czechia, Denmark, France, Greece, Hungary, India, Italy, Japan, Malaysia, Netherlands, Serbia, South Africa, Spain, United Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartNov 2013
First PostedDec 2013
Primary CompletionMay 2015
Study CompletionMay 2017
TodayJul 2026
First PostedDec 9, 2013
Enrollment StartNov 1, 2013
Primary CompletionMay 1, 2015
Study CompletionMay 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 12.6 years ago
Interventions
Micra Pacemaker Implantdevice